article thumbnail

Turning science into business: Merging AI and RNA

Drug Discovery World

For RNA, we’ve seen its success with Covid-19 vaccines and the approval of the first-ever RNA-targeting small molecule, risdiplam, for treating spinal muscular atrophy (SMA). Do you have any therapeutic targets in mind for your first small molecule drug candidate? Is there anything currently in the pipeline?

RNA 130
article thumbnail

Synthetic biology tools advancing and accelerating drug discovery efforts

Drug Discovery World

As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . A story-teller at heart, Ramanathan also delivers science communication workshops. . . . . .

DNA 246